江泽飞-话题@MedSci - 梅斯（MedSci）

#江泽飞#

10篇内容 | 1274人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2180249, encodeId=9596218024965, content=<a href='/topic/show?id=33771982175' target=_blank style='color:#2F92EE;'>#三阴性乳腺癌#</a> <a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a> <a href='/topic/show?id=87b842568dc' target=_blank style='color:#2F92EE;'>#复发或转移性三阴性乳腺癌#</a> <a href='/topic/show?id=333a6802212' target=_blank style='color:#2F92EE;'>#特瑞普利单抗#</a> <a href='/topic/show?id=3fcc109e7757' target=_blank style='color:#2F92EE;'>#Nab-紫杉醇#</a>, objectTitle=Nat Med：江泽飞团队报道特瑞普利单抗联合nab-紫杉醇（nab-P）对转移性或复发性三阴性乳腺癌展示良好疗效（TORCHLIGHT研究）, objectType=article, longId=808671, objectId=f3c58086e1f4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240107/c19320fa11144f48a4732199d8594bc9.jpg, objectUrl=/article/show_article.do?id=f3c58086e1f4, replyNumber=0, likeNumber=0, createdTime=2024-01-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=f3c58086e1f4, moduleTitle=Nat Med：江泽飞团队报道特瑞普利单抗联合nab-紫杉醇（nab-P）对转移性或复发性三阴性乳腺癌展示良好疗效（TORCHLIGHT研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f3c58086e1f4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1755842, encodeId=64781e55842b8, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=2021BOC/BOA：江泽飞教授解读CDK4/6抑制剂阿贝西利中国数据，期待惠及更多乳腺癌患者, objectType=article, longId=210931, objectId=06062109315d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06062109315d, replyNumber=0, likeNumber=71, createdTime=2021-07-25, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06062109315d, moduleTitle=2021BOC/BOA：江泽飞教授解读CDK4/6抑制剂阿贝西利中国数据，期待惠及更多乳腺癌患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=06062109315d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755841, encodeId=7bd91e5584128, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=江泽飞教授：哪些乳腺癌临床实践可以被改变, objectType=article, longId=151215, objectId=e2ea151215b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2ea151215b3, replyNumber=0, likeNumber=130, createdTime=2018-12-12, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2ea151215b3, moduleTitle=江泽飞教授：哪些乳腺癌临床实践可以被改变, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e2ea151215b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755840, encodeId=0d4b1e55840dd, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=江泽飞：乳腺癌内分泌治疗的热点问题, objectType=article, longId=126028, objectId=4ba71260289b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ba71260289b, replyNumber=0, likeNumber=65, createdTime=2018-04-29, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ba71260289b, moduleTitle=江泽飞：乳腺癌内分泌治疗的热点问题, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4ba71260289b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755838, encodeId=444c1e55838ad, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=【CSCO 2017】把握驱动，精准治疗—— 江泽飞教授谈HER2阳性乳腺癌治疗现状, objectType=article, longId=115047, objectId=c8a211504e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8a211504e83, replyNumber=0, likeNumber=108, createdTime=2017-11-22, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8a211504e83, moduleTitle=【CSCO 2017】把握驱动，精准治疗—— 江泽飞教授谈HER2阳性乳腺癌治疗现状, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c8a211504e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755839, encodeId=893c1e558397f, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=[SIBCS2017]江泽飞教授：国际晚期乳腺癌临床实践进展盘点, objectType=article, longId=117553, objectId=f4ab11e55328, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4ab11e55328, replyNumber=0, likeNumber=112, createdTime=2018-10-04, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4ab11e55328, moduleTitle=[SIBCS2017]江泽飞教授：国际晚期乳腺癌临床实践进展盘点, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f4ab11e55328)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755837, encodeId=9a711e5583794, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=江泽飞：浅谈乳腺癌临床治疗前景【medsci专访CSCO2014】, objectType=article, longId=40501, objectId=6de140501f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6de140501f8, replyNumber=0, likeNumber=137, createdTime=2015-01-07, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6de140501f8, moduleTitle=江泽飞：浅谈乳腺癌临床治疗前景【medsci专访CSCO2014】, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6de140501f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755836, encodeId=08ae1e558366f, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=ASCO 2014：江泽飞：早期乳腺癌双靶向预防复发研究（ALTTO研究）, objectType=article, longId=35651, objectId=281135651d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=281135651d0, replyNumber=0, likeNumber=110, createdTime=2014-08-09, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=281135651d0, moduleTitle=ASCO 2014：江泽飞：早期乳腺癌双靶向预防复发研究（ALTTO研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=281135651d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755835, encodeId=860d1e558350e, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=Ann Oncol：江泽飞等发现循环肿瘤细胞为中国乳腺癌患者生存独立预测因素, objectType=article, longId=21614, objectId=f7432161447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7432161447, replyNumber=0, likeNumber=98, createdTime=2014-02-17, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7432161447, moduleTitle=Ann Oncol：江泽飞等发现循环肿瘤细胞为中国乳腺癌患者生存独立预测因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f7432161447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755833, encodeId=91a91e55833da, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=江泽飞：2011乳腺癌领域四大关键词, objectType=article, longId=3949, objectId=14ce394923, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14ce394923, replyNumber=0, likeNumber=85, createdTime=2012-04-26, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14ce394923, moduleTitle=江泽飞：2011乳腺癌领域四大关键词, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=14ce394923)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1755834, encodeId=fa341e5583461, content=<a href='/topic/show?id=57a564331cd' target=_blank style='color:#2F92EE;'>#江泽飞#</a>, objectTitle=江泽飞：晚期乳腺癌全程管理理念和化疗方案选择, objectType=article, longId=5809, objectId=93d0580982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93d0580982, replyNumber=0, likeNumber=121, createdTime=2013-02-09, rootId=0, userName=jktdtl, userId=f3c337051995, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93d0580982, moduleTitle=江泽飞：晚期乳腺癌全程管理理念和化疗方案选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=93d0580982)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

江泽飞

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#三阴性乳腺癌# #江泽飞# #复发或转移性三阴性乳腺癌# #特瑞普利单抗# #Nab-紫杉醇#

Nat Med：江泽飞团队报道特瑞普利单抗联合nab-紫杉醇（nab-P）对转移性或复发性三阴性乳腺癌展示良好疗效（TORCHLIGHT研究）

2024-01-09发表于加利福尼亚

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

2021BOC/BOA：江泽飞教授解读CDK4/6抑制剂阿贝西利中国数据，期待惠及更多乳腺癌患者

2021-07-25

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

江泽飞教授：哪些乳腺癌临床实践可以被改变

2018-12-12

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

江泽飞：乳腺癌内分泌治疗的热点问题

2018-04-29

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

【CSCO 2017】把握驱动，精准治疗—— 江泽飞教授谈HER2阳性乳腺癌治疗现状

2017-11-22

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

[SIBCS2017]江泽飞教授：国际晚期乳腺癌临床实践进展盘点

2018-10-04

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

江泽飞：浅谈乳腺癌临床治疗前景【medsci专访CSCO2014】

2015-01-07

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

ASCO 2014：江泽飞：早期乳腺癌双靶向预防复发研究（ALTTO研究）

2014-08-09

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

Ann Oncol：江泽飞等发现循环肿瘤细胞为中国乳腺癌患者生存独立预测因素

2014-02-17

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

江泽飞：2011乳腺癌领域四大关键词

2012-04-26

jktdtl (审核中...)

前往app查看评论内容

#江泽飞#

江泽飞：晚期乳腺癌全程管理理念和化疗方案选择

2013-02-09

科室
- - 订阅+
  - 更多科室
工具
服务